Metabolism

Items 11-17 of 17

Page
per page
Set Descending Direction
  1. anti-MPC-2, mAb (JCM-1)
    AG-20B-0071
    AG-20B-0071-C100100 µg
    CHF 540.00
  2. anti-Omentin (human), mAb (Lecty-1)
    AG-20B-0031
    AG-20B-0031-C100100 µg
    CHF 190.00
  3. anti-PARP-10 [ARTD10] (human), mAb (5H11)
    AG-20T-0004
    AG-20T-0004-L0011 ml
    CHF 380.00
    Immunofluorescence using anti-PARP-10 [ARTD10] (human), mAb (5H11). Method: T47D mammary carcinoma cells were stained by indirect immunofluorescence and analysed. Prior to fixation and staining, the cells were treated with or without 50nm leptomyci
  4. anti-Poly(ADP-ribose) [PAR], mAb (10H)
    AG-20T-0001
    AG-20T-0001-C05050 µg
    CHF 190.00
    AG-20T-0001-C100100 µg
    CHF 290.00
    AG-20T-0001-M0011 mg
    CHF 860.00
    anti-Poly(ADP-ribose) [PAR], mAb (10H)
  5. anti-Sirtuin 2 (human), mAb (S2R233-1)
    AG-20A-0076
    AG-20A-0076-C05050 µg
    CHF 270.00
    AG-20A-0076-C100100 µg
    CHF 350.00
    Western blot analysis using anti-Sirtuin 2 (human), mAb (S2R233-1) (Prod. No. AG-20A-0076) at 1:4'000 dilution.1: Human sirtuin 2 (His-tagged).2: Human sirtuin 1 (His-tagged).3: Human sirtuin 5 (His-tagged).4: Human sirtuin 6 (His-
  6. anti-Sirtuin 6 (human), mAb (S6R82-2)
    AG-20A-0091
    AG-20A-0091-C05050 µg
    CHF 110.00
    AG-20A-0091-C100100 µg
    CHF 190.00
    Western blot analysis using anti-Sirtuin 6 (human), mAb (S6R82-2) (Prod. No. AG-20A-0091) at 1:2'000 dilution.1: Human sirtuin 6 (His-tagged).2: Human sirtuin 1 (His-tagged).3: Human sirtuin 2 (His-tagged).4: Human sirtuin 5 (His-t
  7. anti-Vaspin (human), mAb (VP63)
    AG-20A-0045
    AG-20A-0045-C05050 µg
    CHF 310.00
    AG-20A-0045-C100100 µg
    CHF 430.00
    Immunohistochemical staining of vaspin with anti-Vaspin (human), mAb (VP63) (AG-20A-0045) in psoriatic skin lesions (A). Negative control for vaspin in psoriatic skin lesions (B). Blue hematoxylin stained cell nuclei.

Items 11-17 of 17

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.